These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4061277)

  • 61. [Europeanisation of law. Demarcation issues in court].
    Schemmer F
    Pharm Unserer Zeit; 2011 Jul; 40(4):345-50. PubMed ID: 21698634
    [No Abstract]   [Full Text] [Related]  

  • 62. The DEA arrives.
    Kelley ET
    Clin Toxicol; 1977; 11(1):121-3. PubMed ID: 872536
    [No Abstract]   [Full Text] [Related]  

  • 63. APhA government affairs annual report.
    Am Pharm; 1987 Feb; NS27(2):35-8. PubMed ID: 3565249
    [No Abstract]   [Full Text] [Related]  

  • 64. Drug enforcement policy as a factor in trends of trafficking and use of different substances.
    Arnao G
    J Psychoactive Drugs; 1988; 20(4):463-5. PubMed ID: 3244068
    [No Abstract]   [Full Text] [Related]  

  • 65. FDA gathers information for plans to regulate nanoscale drugs.
    Lavine G
    Am J Health Syst Pharm; 2008 Nov; 65(21):1988, 1990. PubMed ID: 18945848
    [No Abstract]   [Full Text] [Related]  

  • 66. Drug licensing or innovation.
    Lancet; 1981 Oct; 2(8250):788. PubMed ID: 6116910
    [No Abstract]   [Full Text] [Related]  

  • 67. [The concept of determining national requirements of essential drugs].
    Meshkovskiĭ AP
    Sov Zdravookhr; 1990; (11):62-5. PubMed ID: 2075502
    [No Abstract]   [Full Text] [Related]  

  • 68. A growing industry and menace: makeshift laboratory's designer drugs.
    Ziporyn T
    JAMA; 1986 Dec; 256(22):3061-3. PubMed ID: 3491222
    [No Abstract]   [Full Text] [Related]  

  • 69. A simple solution to "legitimate prescribing" of street drugs.
    Selander GT
    J Fla Med Assoc; 1978 Jun; 65(6):439-40. PubMed ID: 660151
    [No Abstract]   [Full Text] [Related]  

  • 70. Methaqualone abuse implicated in injuries, deaths nationwide.
    Gonzalez ER
    JAMA; 1981 Aug; 246(8):813-5, 819. PubMed ID: 7253147
    [No Abstract]   [Full Text] [Related]  

  • 71. Misadventures in the use of medicines.
    Am J Hosp Pharm; 1989 May; 46(5):925. PubMed ID: 2729300
    [No Abstract]   [Full Text] [Related]  

  • 72. ["Demarcation issues" - an unusual subject in Pharmazie in unserer Zeit? Not at all!].
    Knöss W; Dingermann T
    Pharm Unserer Zeit; 2011 Jul; 40(4):293. PubMed ID: 21695705
    [No Abstract]   [Full Text] [Related]  

  • 73. Phenytoin should be considered a critical drug.
    Steinhauser KJ
    Am J Hosp Pharm; 1988 Aug; 45(8):1667-8. PubMed ID: 3218642
    [No Abstract]   [Full Text] [Related]  

  • 74. The EMA perspective: case studies from the PDCO formulations group (chemicals & biologicals).
    Lebarbier C; Esteve I
    Int J Pharm; 2012 Oct; 435(2):131-2. PubMed ID: 22883694
    [No Abstract]   [Full Text] [Related]  

  • 75. Legalizing drugs?
    Alexander LL
    J Natl Med Assoc; 1990 Nov; 82(11):753, 804. PubMed ID: 2073289
    [No Abstract]   [Full Text] [Related]  

  • 76. Regulations which govern the availability of therapeutic drugs in Australia.
    Shaw J
    J Clin Pharmacol; 1988 Oct; 28(10):889-93. PubMed ID: 3220963
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Should drugs be legalized?].
    Fontaine B
    Soins; 1991 Feb; (545):43-4. PubMed ID: 2024195
    [No Abstract]   [Full Text] [Related]  

  • 78. Street drug misrepresentation.
    Falck R; Seal M
    JAMA; 1980 Jul; 244(4):332. PubMed ID: 7392120
    [No Abstract]   [Full Text] [Related]  

  • 79. Doctors and their responsibility in the legalisation debate.
    Svae A
    Tidsskr Nor Laegeforen; 2015 Apr; 135(7):637. PubMed ID: 25899365
    [No Abstract]   [Full Text] [Related]  

  • 80. The medicines act and "me-too" drugs.
    Drug Ther Bull; 1976 Aug; 14(17):65-6. PubMed ID: 964134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.